Technical Analysis for ACHV - Achieve Life Sciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Golden Cross | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Stochastic Reached Overbought | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 3.99% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 17 hours ago |
2x Volume Pace | about 17 hours ago |
1.5x Volume Pace | about 17 hours ago |
Up 3% | about 17 hours ago |
Up 2% | about 17 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 8.37 |
52 Week Low | 3.03 |
Average Volume | 105,651 |
200-Day Moving Average | 4.53 |
50-Day Moving Average | 4.55 |
20-Day Moving Average | 4.64 |
10-Day Moving Average | 4.76 |
Average True Range | 0.24 |
RSI (14) | 69.04 |
ADX | 10.93 |
+DI | 28.06 |
-DI | 15.21 |
Chandelier Exit (Long, 3 ATRs) | 4.63 |
Chandelier Exit (Short, 3 ATRs) | 5.07 |
Upper Bollinger Bands | 5.02 |
Lower Bollinger Band | 4.26 |
Percent B (%b) | 1.25 |
BandWidth | 16.40 |
MACD Line | 0.12 |
MACD Signal Line | 0.06 |
MACD Histogram | 0.0546 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.63 | ||||
Resistance 3 (R3) | 5.63 | 5.49 | 5.56 | ||
Resistance 2 (R2) | 5.49 | 5.38 | 5.49 | 5.54 | |
Resistance 1 (R1) | 5.35 | 5.32 | 5.42 | 5.35 | 5.51 |
Pivot Point | 5.21 | 5.21 | 5.25 | 5.21 | 5.21 |
Support 1 (S1) | 5.07 | 5.10 | 5.14 | 5.07 | 4.91 |
Support 2 (S2) | 4.93 | 5.04 | 4.93 | 4.88 | |
Support 3 (S3) | 4.79 | 4.93 | 4.86 | ||
Support 4 (S4) | 4.79 |